AdaptHealth Corp.
AHCOUS売上高
$3.2B
百万USD
営業利益
$91M
百万USD
純利益
$-71M
百万USD
ROE
-4.7%
最新FY
EPS
$-0.52
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $482M | $-4M | $-0.08 |
| FY2021 | Q2 | $617M | $79M | $0.12 |
| FY2021 | Q3 | $653M | $58M | $0.20 |
| FY2021 | FY | $2.5B | $156M | $0.67 |
| FY2022 | Q1 | $706M | $42M | $0.08 |
| FY2022 | Q2 | $728M | $14M | $0.09 |
| FY2022 | Q3 | $756M | $16M | $0.11 |
| FY2022 | FY | $3.0B | $69M | $0.33 |
| FY2023 | Q1 | $745M | $16M | $-0.06 |
| FY2023 | Q2 | $793M | $14M | $0.09 |
| FY2023 | Q3 | $804M | $-454M | $-3.43 |
| FY2023 | FY | $3.2B | $-679M | $-5.31 |
| FY2024 | Q1 | $792M | $-2M | $-0.02 |
| FY2024 | Q2 | $806M | $19M | $0.13 |
| FY2024 | Q3 | $806M | $23M | $0.15 |
| FY2024 | FY | $3.3B | $90M | $0.61 |
| FY2025 | Q1 | $778M | $-7M | $-0.05 |
| FY2025 | Q2 | $800M | $15M | $0.10 |
| FY2025 | Q3 | $820M | $25M | $0.16 |
| FY2025 | FY | $3.2B | $-71M | $-0.52 |
| FY2026 | Q1 | $820M | $-16M | $-0.12 |
財務データ
| 指標 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| 売上高 | - | $530M | $1.1B | $2.5B | $3.0B | $3.2B | $3.3B | $3.2B |
| 営業利益 | $-1M | $30M | $71M | $226M | $190M | $-598M | $264M | $91M |
| 純利益 | $2M | $-15M | $-162M | $156M | $69M | $-679M | $90M | $-71M |
| 総資産 | $254M | $546M | $1.8B | $5.3B | $5.2B | $4.5B | $4.5B | $4.3B |
| 純資産 | - | $-29M | $281M | $2.1B | $2.2B | $1.5B | $1.6B | $1.5B |
| 自己資本 | $5M | $-15M | $355M | $2.1B | $2.2B | $1.5B | $1.6B | $1.5B |
| 営業CF | $-2M | $60M | $196M | $276M | $374M | $481M | $542M | $602M |
| EPS | - | - | - | $0.67 | $0.33 | $-5.31 | $0.61 | $-0.52 |
| BPS | $0.16 | - | - | $15.40 | $15.88 | $10.97 | $11.65 | $11.17 |
| ROE | 41.7% | 103.3% | -45.5% | 7.6% | 3.2% | -46.5% | 5.8% | -4.7% |